Cairn Investment Group, Inc. Novo Nordisk A S Transaction History

Cairn Investment Group, Inc.

$191 Million
Q2 2025

A detailed history of Cairn Investment Group, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Cairn Investment Group, Inc. holds 10,328 shares of NVO stock, worth $514,127. This represents 0.37% of its overall portfolio holdings.

Number of Shares

10,328

Previous 9,882 4.51%

Holding current value

$514,127

Previous $686,000 3.94%

% of portfolio

0.37%

Previous 0.39%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	BUY	$58.08 - $81.05 $25,903 - $36,148	446 Added 4.51%	10,328 $713,000
Q1 2025 Apr 25, 2025	SELL	$69.3 - $90.95 $11,642 - $15,279	-168 Reduced 1.67%	9,882 $686,000
Q4 2024 Jan 23, 2025	SELL	$85.0 - $120.04 $739,500 - $1.04 Million	-8,700 Reduced 46.4%	10,050 $865,000
Q3 2024 Oct 17, 2024	SELL	$119.07 - $145.42 $23,814 - $29,083	-200 Reduced 1.06%	18,750 $2.23 Million
Q2 2024 Aug 06, 2024	SELL	$122.71 - $146.91 $24,542 - $29,382	-200 Reduced 1.04%	18,950 $2.71 Million
Q1 2024 Apr 15, 2024	SELL	$102.11 - $135.92 $3,063 - $4,077	-30 Reduced 0.16%	19,150 $2.46 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $4,389 - $5,272	-50 Reduced 0.26%	19,180 $1.98 Million
Q3 2023 Nov 06, 2023	BUY	$90.94 - $199.54 $869,841 - $1.91 Million	9,565 Added 98.97%	19,230 $1.75 Million
Q2 2023 Aug 01, 2023	SELL	$155.98 - $172.65 $9,358 - $10,359	-60 Reduced 0.62%	9,665 $1.56 Million
Q1 2023 Apr 24, 2023	SELL	$132.34 - $159.14 $1.12 Million - $1.35 Million	-8,500 Reduced 46.64%	9,725 $1.55 Million
Q4 2022 Jan 11, 2023	BUY	$102.55 - $135.33 $26,663 - $35,185	260 Added 1.45%	18,225 $2.47 Million
Q3 2022 Oct 13, 2022	SELL	$95.28 - $116.93 $60,502 - $74,250	-635 Reduced 3.41%	17,965 $1.79 Million
Q2 2022 Jul 28, 2022	SELL	$103.24 - $121.81 $874,442 - $1.03 Million	-8,470 Reduced 31.29%	18,600 $2.07 Million
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $35,955 - $43,905	-375 Reduced 1.37%	27,070 $3.03 Million
Q3 2021 Nov 09, 2021	SELL	$84.42 - $106.62 $29,547 - $37,317	-350 Reduced 1.26%	27,445 $2.63 Million
Q1 2021 May 04, 2021	SELL	$67.06 - $75.82 $12,406 - $14,026	-185 Reduced 0.66%	27,795 $1.87 Million
Q4 2020 Feb 02, 2021	SELL	$63.89 - $73.8 $702,790 - $811,800	-11,000 Reduced 28.22%	27,980 $1.95 Million
Q3 2020 Nov 02, 2020	SELL	$63.69 - $70.22 $136,615 - $150,621	-2,145 Reduced 5.22%	38,980 $2.71 Million
Q2 2020 Jul 21, 2020	SELL	$58.54 - $67.94 $105,079 - $121,952	-1,795 Reduced 4.18%	41,125 $2.69 Million
Q1 2020 Apr 24, 2020	BUY	$49.46 - $64.78 $741 - $971	15 Added 0.03%	42,920 $2.58 Million
Q4 2019 Jan 30, 2020	BUY	$49.86 - $58.26 $2.14 Million - $2.5 Million	42,905 New	42,905 $2.48 Million

Others Institutions Holding NVO

# of Institutions

1,744

Shares Held

337M

Call Options Held

10.7M

Put Options Held

16M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $112B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cairn Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cairn Investment Group, Inc. with notifications on news.

Account

Cairn Investment Group, Inc. Novo Nordisk A S Transaction History